Sapphiros Awarded $11M to Develop Over-the-Counter Respiratory Test
Sapphiros was selected by the NIH RADx Tech program to develop an over-the-counter, molecular multiplex respiratory diagnostic test.
Read MorePosted by Andy Lundin | Apr 17, 2023 | Respiratory Disease |
Sapphiros was selected by the NIH RADx Tech program to develop an over-the-counter, molecular multiplex respiratory diagnostic test.
Read MorePosted by Eli Patterson | Apr 13, 2023 | Molecular Diagnostics |
Most current molecular tests have been developed as laboratory-developed tests, outside the strict regulatory framework of the FDA.
Read MorePosted by Andy Lundin | Apr 13, 2023 | Cancer |
Researchers say newly reported cases of cancer diagnoses declined 14.4% in 2020 compared with prior years.
Read MorePosted by Andy Lundin | Apr 12, 2023 | Molecular Diagnostic Analyzers |
PathogenDx expanded the reach of its patented multiplexed molecular testing technology, Dynamic Dimensional Detection (D3 Array).
Read MorePosted by Andy Lundin | Apr 10, 2023 | Diagnostic Technologies |
LifeQ says it can detect as many as 40 cardiovascular and sleep disorders with smartwatches and other wearable devices.
Read More